Orit Markowitz1, Michelle Schwartz1, Eleanor Feldman1, Amanda Bienenfeld1, Amy K Bieber1, Jeffery Ellis2, Usha Alapati3, Mark Lebwohl4, Daniel M Siegel3. 1. Mount Sinai Medical Center, New York, New York; ; New York Harbor Healthcare System, Brooklyn Campus, Brooklyn New York; ; Downstate Medical Center, Brooklyn, New York; 2. Downstate Medical Center, Brooklyn, New York; ; Belaray Dermatology, Hicksville, New York. 3. New York Harbor Healthcare System, Brooklyn Campus, Brooklyn New York; ; Downstate Medical Center, Brooklyn, New York; 4. Mount Sinai Medical Center, New York, New York;
Abstract
OBJECTIVE: To determine the diagnostic accuracy of optical coherence tomography for basal cell carcinoma and the proportion of biopsies that could be avoided if optical coherence tomography is used to rule-in surgery. DESIGN: Multicenter, prospective, observational study. SETTING: Dermatology clinics. PARTICIPANTS: Consecutive patients with clinically challenging pink lesions suspicious for basal cell carcinoma. MEASUREMENTS: Clinical, dermoscopic, and optical coherence tomography images were obtained for all subjects. At each stage, the clinician made a diagnosis (pathology + subtype if applicable), and assessed his/her own confidence in the diagnosis. RESULTS: Optical coherence tomography significantly (p<0.01) improved sensitivity and specificity over clinical or dermoscopic evaluation. The percentage of correct diagnoses was 57.4 percent (clinical), 69.6 percent (dermoscopy), and 87.8 percent (optical coherence tomography). Optical coherence tomography significantly increased the certainty of diagnosis; clinicians indicated they were certain (>95% confident) in 17 percent of lesions examined clinically, in 38.6 percent examined with dermoscopy, and in 70 percent examined with optical coherence tomography. With the use of optical coherence tomography in the diagnosis of basal cell carcinoma, more than 1 in 3 patients could avoid a diagnostic biopsy. CONCLUSION: In a population of clinically challenging lesions, optical coherence tomography improved diagnostic certainty by a factor of four over clinical examination alone and improved diagnostic accuracy by 50 percent (57-88%). The addition of optical coherence tomography to other standard assessments can improve the false-positive rate and give a high degree of certainty for ruling in a positive diagnosis for basal cell carcinoma. A reduction of 36 percent in overall biopsies could be achieved by sending high certainty basal cell carcinoma positive optical coherence tomography diagnoses straight to surgery.
OBJECTIVE: To determine the diagnostic accuracy of optical coherence tomography for basal cell carcinoma and the proportion of biopsies that could be avoided if optical coherence tomography is used to rule-in surgery. DESIGN: Multicenter, prospective, observational study. SETTING: Dermatology clinics. PARTICIPANTS: Consecutive patients with clinically challenging pink lesions suspicious for basal cell carcinoma. MEASUREMENTS: Clinical, dermoscopic, and optical coherence tomography images were obtained for all subjects. At each stage, the clinician made a diagnosis (pathology + subtype if applicable), and assessed his/her own confidence in the diagnosis. RESULTS: Optical coherence tomography significantly (p<0.01) improved sensitivity and specificity over clinical or dermoscopic evaluation. The percentage of correct diagnoses was 57.4 percent (clinical), 69.6 percent (dermoscopy), and 87.8 percent (optical coherence tomography). Optical coherence tomography significantly increased the certainty of diagnosis; clinicians indicated they were certain (>95% confident) in 17 percent of lesions examined clinically, in 38.6 percent examined with dermoscopy, and in 70 percent examined with optical coherence tomography. With the use of optical coherence tomography in the diagnosis of basal cell carcinoma, more than 1 in 3 patients could avoid a diagnostic biopsy. CONCLUSION: In a population of clinically challenging lesions, optical coherence tomography improved diagnostic certainty by a factor of four over clinical examination alone and improved diagnostic accuracy by 50 percent (57-88%). The addition of optical coherence tomography to other standard assessments can improve the false-positive rate and give a high degree of certainty for ruling in a positive diagnosis for basal cell carcinoma. A reduction of 36 percent in overall biopsies could be achieved by sending high certainty basal cell carcinoma positive optical coherence tomography diagnoses straight to surgery.
Authors: T Maier; M Braun-Falco; T Hinz; M H Schmid-Wendtner; T Ruzicka; C Berking Journal: J Eur Acad Dermatol Venereol Date: 2012-04-28 Impact factor: 6.166
Authors: Mette Mogensen; Thomas Martini Joergensen; Birgit Meincke Nürnberg; Hanan Ahmad Morsy; Jakob B Thomsen; Lars Thrane; Gregor B E Jemec Journal: Dermatol Surg Date: 2009-04-08 Impact factor: 3.398
Authors: Sophie C Flohil; Inge Seubring; Michelle M van Rossum; Jan-Willem W Coebergh; Esther de Vries; Tamar Nijsten Journal: J Invest Dermatol Date: 2012-11-29 Impact factor: 8.551
Authors: Ethan Walker; Yiqiao Liu; InYoung Kim; David L Wilson; James P Basilion; Daniel L Popkin; Mark Biro; Sukanya Raj Iyer; Harib Ezaldein; Jeffrey Scott; Miesha Merati; Rachel Mistur; Bo Zhou; Brian Straight; Joshua J Yim; Matthew Bogyo; Margaret Mann Journal: Cancer Res Date: 2020-03-04 Impact factor: 12.701
Authors: Tahereh Marvdashti; Lian Duan; Sumaira Z Aasi; Jean Y Tang; Audrey K Ellerbee Bowden Journal: Biomed Opt Express Date: 2016-08-29 Impact factor: 3.732
Authors: Yan Li; Raksha Sreeramachandra Murthy; Yirui Zhu; Fengyi Zhang; Jianing Tang; Joseph N Mehrabi; Kristen M Kelly; Zhongping Chen Journal: IEEE Trans Med Imaging Date: 2021-08-31 Impact factor: 11.037
Authors: Jacqueline Dinnes; Jonathan J Deeks; Naomi Chuchu; Rubeta N Matin; Kai Yuen Wong; Roger Benjamin Aldridge; Alana Durack; Abha Gulati; Sue Ann Chan; Louise Johnston; Susan E Bayliss; Jo Leonardi-Bee; Yemisi Takwoingi; Clare Davenport; Colette O'Sullivan; Hamid Tehrani; Hywel C Williams Journal: Cochrane Database Syst Rev Date: 2018-12-04
Authors: Jacqueline Dinnes; Jonathan J Deeks; Naomi Chuchu; Lavinia Ferrante di Ruffano; Rubeta N Matin; David R Thomson; Kai Yuen Wong; Roger Benjamin Aldridge; Rachel Abbott; Monica Fawzy; Susan E Bayliss; Matthew J Grainge; Yemisi Takwoingi; Clare Davenport; Kathie Godfrey; Fiona M Walter; Hywel C Williams Journal: Cochrane Database Syst Rev Date: 2018-12-04